Increasing Genomic Stability to Decrease Cancer

Cancer can be boiled down to a question of stability. "Genomic instability is, in essence, the final common denominator in the ... evolution of cancer," comments Errol C. Friedberg, professor of pathology at University of Texas Southwestern Medical Center at Dallas. Defects to a cell's genome--whether they be mutations or damage caused by ultraviolet (UV) rays--that don't get fixed through DNA repair mechanisms will be passed on to new cells, he notes. "Anybody interested in understanding the

Written byPaul Smaglik
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Cancer can be boiled down to a question of stability.

"Genomic instability is, in essence, the final common denominator in the ... evolution of cancer," comments Errol C. Friedberg, professor of pathology at University of Texas Southwestern Medical Center at Dallas. Defects to a cell's genome--whether they be mutations or damage caused by ultraviolet (UV) rays--that don't get fixed through DNA repair mechanisms will be passed on to new cells, he notes. "Anybody interested in understanding the pathogenesis of cancer wants to understand how genomic stability is maintained," Friedberg continues. "Anything that is important in maintaining genetic stability is probably important in protecting your cells against cancer. Any kind of gene defect that promotes genomic instability probably is a cancer-predisposing gene of some kind."

Manipulating repair systems could restore stability to the genome and reduce cancer risks, notes James Cleaver, professor of dermatology at the University of California at San ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies